Mustafa KORKMAZ,
Melek KARAKURT ERYILMAZ,
Mehmet Zahid KOÇAK,
Aykut DEMİRKIRAN,
Murat ARAZ,
Mustafa KARAAĞAÇ,
Mehmet ARTAÇ
A new prognostic factor in patients with recurrent glioblastoma multiforme treated with bevacizumab plus irinotecan: Hemoglobin, albumin, lymphocytes and platelets (HALP) score
A new prognostic factor in patients with recurrent glioblastoma multiforme treated with bevacizumab plus irinotecan: Hemoglobin, albumin, lymphocytes and platelets (HALP) score
Archives of Current Medical Research
2023-Cilt: 4 - Sayı: 1
19-23
Bevacizumab,
Glioblastoma multiforme,
HALP,
Prognostic marker
290
98